Bioregenx BRGX
OTC BRGX
$0.00 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Bioregenx, Inc. (BRGX) EBITDA (2023 - 2026)

Updated

Bioregenx (BRGX) recorded EBITDA of -$36,821 in Q1 2026, compared with -$180,238 a year earlier.

Analysis

Bioregenx, Inc. (BRGX) EBITDA (2023 - 2026) Analysis & Trends

On a TTM basis, Bioregenx's EBITDA came in at -$1.03 million as of Mar 31, 2026; for FY2025, it came in at -$1.17 million.

  • Across earlier years, EBITDA came in at -$20.54 million in FY2024 and -$3.4 million in FY2023.
  • Quarterly EBITDA has ranged from -$17.74 million in Q4 2024 to $247,159 in Q3 2024 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$922,713 (Q4 2025), $3,918 (Q3 2025) and -$69,882 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -36,821.00
Dec 31, 2025 -922,713.00
Sep 30, 2025 5,894.00
Jun 30, 2025 -71,078.00
Mar 31, 2025 -178,723.00
Dec 31, 2024 -17.73 Mn
Sep 30, 2024 255,768.00
Jun 30, 2024 -456,493.00
Mar 31, 2024 -2.57 Mn
Dec 31, 2023 -208,878.00
Sep 30, 2023 -2.47 Mn
Jun 30, 2023 -541,943.00
Mar 31, 2023 -181,429.00
API Access

Bioregenx, Inc. EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=BRGX&period=max&api_key=YOUR_API_KEY